Verity Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.63M Sell
19,670
-132
-0.7% -$10.9K 0.78% 35
2025
Q1
$1.61M Buy
19,802
+117
+0.6% +$9.49K 0.65% 46
2024
Q4
$1.77M Sell
19,685
-404
-2% -$36.4K 1% 25
2024
Q3
$1.98M Buy
20,089
+179
+0.9% +$17.7K 0.75% 30
2024
Q2
$1.85M Buy
19,910
+1,765
+10% +$164K 0.72% 35
2024
Q1
$1.72M Buy
18,145
+777
+4% +$73.7K 0.96% 21
2023
Q4
$1.55M Buy
17,368
+140
+0.8% +$12.5K 0.99% 22
2023
Q3
$1.26M Buy
17,228
+1,266
+8% +$92.4K 0.93% 26
2023
Q2
$1.33M Buy
15,962
+203
+1% +$16.9K 0.99% 21
2023
Q1
$1.2M Buy
15,759
+782
+5% +$59.6K 0.72% 39
2022
Q4
$1.24M Buy
14,977
+121
+0.8% +$10K 1.06% 25
2022
Q3
$1.18M Buy
+14,856
New +$1.18M 1.22% 16
2022
Q1
$1.26M Buy
14,052
+2,642
+23% +$237K 0.8% 29
2021
Q4
$1.28M Sell
11,410
-127
-1% -$14.2K 0.75% 23
2021
Q3
$1.45M Buy
11,537
+192
+2% +$24.1K 0.94% 19
2021
Q2
$1.54M Buy
11,345
+380
+3% +$51.4K 0.84% 22
2021
Q1
$1.49M Sell
10,965
-1,755
-14% -$238K 0.89% 23
2020
Q4
$1.79M Sell
12,720
-3,140
-20% -$442K 1.25% 18
2020
Q3
$1.77M Buy
15,860
+1,400
+10% +$156K 1.34% 11
2020
Q2
$1.62M Sell
14,460
-2,754
-16% -$308K 1.49% 10
2020
Q1
$1.33M Sell
17,214
-1,330
-7% -$103K 1.68% 14
2019
Q4
$1.76M Sell
18,544
-1,193
-6% -$113K 1.76% 4
2019
Q3
$1.51M Sell
19,737
-1,278
-6% -$97.5K 1.58% 8
2019
Q2
$1.84M Sell
21,015
-205
-1% -$18K 2.07% 6
2019
Q1
$1.92M Sell
21,220
-239
-1% -$21.6K 2.22% 7
2018
Q4
$1.54M Buy
21,459
+1,757
+9% +$126K 2.06% 11
2018
Q3
$1.89M Sell
19,702
-5,892
-23% -$565K 1.86% 11
2018
Q2
$2.44M Buy
25,594
+22,234
+662% +$2.12M 2.2% 8
2018
Q1
$295K Sell
3,360
-719
-18% -$63.1K 0.27% 74
2017
Q4
$381K Buy
4,079
+42
+1% +$3.92K 0.29% 59
2017
Q3
$338K Buy
+4,037
New +$338K 0.26% 65